COMPASS
Exact Sciences, Mayo Clinic, University of Utah, American Cancer Society, and Fight Colorectal Cancer (Fight CRC) are working together on a clinical study to evaluate what impact an educational video about colorectal cancer screening has on patients completing their colorectal cancer screenings. Adults ages 45 to 70 who are scheduled for a primary care appointment, at average risk for colorectal cancer (CRC), and are due for CRC screening may be eligible to enroll. In addition to viewing the video, participants will be asked to complete several surveys over a 6-year study period.
For more information, refer to the link below.
VOYAGE
For more information, refer to the link below.
CORRECT-II
Exact Sciences, National Surgical Adjuvant Breast and Bowel Project (NSABP) and Fight Colorectal Cancer (Fight CRC) are working together on an observational study called CORRECT-II, enrolling Stage II and Stage III colorectal cancer patients. The aim of this study is to collect multiple blood samples over 5 years to evaluate if an investigational blood test is able to predict colorectal cancer recurrence by detecting minimal residual disease (MRD).
For more information, refer to the clinicaltrials.gov link below. To find a participating site near you, please contact the NSABP Department of Site and Study Management at 1-800-270-3165 or by e-mail at industry.trials@nsabp.org.
ALTUS
Exact Sciences is currently conducting a clinical study called ALTUS, which is enrolling patients who are at increased risk for a type of liver cancer called hepatocellular carcinoma (HCC). In the study, participants will have radiology exams to check if HCC is developing and also provide blood samples for the Oncoguard® Liver blood test. The goal of the ALTUS study is to determine how well the Oncoguard Liver blood test can detect HCC in this patient population.
For more information, refer to the link below.